[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-349274-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-349274-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","diabetes-related-barriers-to-cancer-screening-in-women-with-type-2-diabetes-a-qualitative-interview-study","Diabetes-related barriers to cancer screening in women with type 2 diabetes - A qualitative interview study","","Objectives: People with type 2 diabetes (T2DM) face higher risk of breast and bowel cancers, yet women with diabetes participate less in screening than women without diabetes. This qualitative interview study aimed to identify diabetes-related barriers to cancer screening and potential approaches to address them among women with T2DM. Design: In-depth qualitative interviews. Methods: Semi-structured interviews with 25 women with T2DM aged 50–74 in England, analyzed using the framework method.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/diabetes-related-barriers-to-cancer-screening-in-women-with-type-2-diabetes-a-qualitative-interview-study/349274/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/diabetes-related-barriers-to-cancer-screening-in-women-with-type-2-diabetes-a-qualitative-interview-study/349274.png","ImageObject",300,407,{"name":42,"@type":43},"Mabel","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-23","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",9,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What problem does the study address about women with type 2 diabetes?","Question",{"text":63,"@type":64},"Women with type 2 diabetes have a higher likelihood of developing breast and bowel cancers, yet cancer screening participation is lower than among women without diabetes.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How was the study conducted?",{"text":68,"@type":64},"The study used semi-structured in-depth qualitative interviews with 25 women with type 2 diabetes aged 50 to 74 years living in England, with analysis using the framework method.",{"name":70,"@type":61,"acceptedAnswer":71},"What barriers to cancer screening were identified?",{"text":72,"@type":64},"Barriers included an accumulated high burden of illness and treatment that reduced physical and psychological capacity and practical resources, diabetes-related complications during screening, and limited promotion of T2DM-increased cancer risk within diabetes care.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},349274,1790194036,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":33,"preview_urls":146},7971474920318,"https://ap-avatar.wpscdn.com/avatar/74000ee537e6b0ca360?x-image-process=image/resize,m_fixed,w_180,h_180&k=1788430171632181674","Received: 19 September 2025 | Accepted: 30 May 2026  \nDOI: 10.1111/bjhp.70088  \nOR IG I NA L A RT IC L E  \nDiabetes-related barriers to cancer screening in women with type 2 diabetes: A qualitative interview study  \nRebecca Spencer1  | Georgina Jones1 | Siobhán McHugh1 |  \n2 3 1  \nRamzi A. Ajjan | Rebecca J. Birch | Laura Ashley  \n1School of Humanities and Social Sciences, Leeds Beckett University, Leeds, UK  \n2Leeds Institute of Cardiovascular and Metabolic Medicine, School of Medicine, University of Leeds, Leeds, UK  \n3Leeds Institute for Medical Research, School of Medicine, University of Leeds, Leeds, UK  \nCorrespondence  \nRebecca Spencer, School of Humanities and Social Sciences, Leeds Beckett University, City Campus, Leeds, LS1 3HE, UK.  \nEmail: [rebecca. spencer@leedsbeckett.ac.uk](rebecca. spencer@leedsbeckett.ac.uk)  \nFunding information  \nLeeds Beckett University; University of Leeds  \nAbstract  \nObjectives: People with type 2 diabetes (T2DM) are more likely to develop breast and bowel cancers. Despite this, cancer screening participation is lower among women with diabetes than among women without diabetes, indicating diabetes-related barriers to screening, but little research has examined this. This study aimed to identify and understand diabetes-related barriers to cancer screening, and potential ways to address these, among women with T2DM.  \nDesign: In-depth qualitative interviews.  \nMethods: Semi-structured interviews with 25 women with T2DM, aged 50 to 74 years, living in England. Participants were recruited via diabetic eye screening clinics and community advertisement. Data were analysed to develop themes, using the framework method.  \nResults: Women with T2DM were often living with an accumulated high burden of illness and its treatment, due to diabetes and comorbidities, which reduced their capacity to participate in cancer screening (e.g. physical and psychological capacities; practical resources). Having diabetes could complicate taking part in screening tests for some people (e.g. physical difficulties during screening related to diabetes, its treatment, complications or comorbidities; having to consider glycaemic control during appointments). There appeared to be underappreciation of the T2DM-increased risk of cancer, and limited cancer screening promotion within diabetes care.  \nConclusions: Despite self-reported cancer screening uptake being high among study participants, having diabetes appeared to heighten common barriers to cancer screening  \nThis is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.  \n© 2026 The Author(s). British Journal of Health Psychology published by John Wiley & Sons Ltd on behalf of British Psychological Society.  \nBr J Health Psychol. 2026;[31:e70088.](31:e70088. wileyonlinelibrary.com/journal/bjhp | 1 of 21)[ wileyonlinelibrary.com/journal/bjhp](31:e70088. wileyonlinelibrary.com/journal/bjhp | 1 of 21)[ |](31:e70088. wileyonlinelibrary.com/journal/bjhp | 1 of 21)[ 1 of 21](31:e70088. wileyonlinelibrary.com/journal/bjhp | 1 of 21)  \n[https://doi.org/10.1111/bjhp.70088](https://doi.org/10.1111/bjhp.70088)  \n([e.g. travel-related](e.g. travel-related), logistical and scheduling barriers), whilst also posing additional unique barriers (e.g. diabetes-related stigma and embarrassment). Several potential strategies are suggested to improve cancer screening informed decisionmaking and participation among people with T2DM.  \nK E Y WO R D S  \nbowel screening, breast screening, cancer, cancer screening, cervical screening, diabetes, qualitative  \nStatement of Contribution  \nWhat is already known on this subject?  \n• People with type 2 diabetes (T2DM) are more likely to develop breast and bowel cancers and experience worse cancer-related outcomes.  \n• Women with diabetes are less likely to participate in routine cervical, breast and bowel canc","cbCaiteBgWbP8Y91","https://ap.wps.com/l/cbCaiteBgWbP8Y91","pdf",535886,21,"English","# Abstract\n## Objectives\n## Design\n## Methods\n## Results\n## Conclusions\n# Statement of Contribution\n## What is already known on this subject?\n## What does this study add?\n# Introduction","[{\"question\":\"What problem does the study address about women with type 2 diabetes?\",\"answer\":\"Women with type 2 diabetes have a higher likelihood of developing breast and bowel cancers, yet cancer screening participation is lower than among women without diabetes.\"},{\"question\":\"How was the study conducted?\",\"answer\":\"The study used semi-structured in-depth qualitative interviews with 25 women with type 2 diabetes aged 50 to 74 years living in England, with analysis using the framework method.\"},{\"question\":\"What barriers to cancer screening were identified?\",\"answer\":\"Barriers included an accumulated high burden of illness and treatment that reduced physical and psychological capacity and practical resources, diabetes-related complications during screening, and limited promotion of T2DM-increased cancer risk within diabetes care.\"}]","Diabetes-related barriers to cancer screening in women with type 2 diabetes - A qualitative interview study | PDF",1790082558,53,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/0dee547bc9c8d44e4201347c30abe8de.webp",983,1414,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/6481e45b4ddef9686838f8ac7b37f1b1.webp",982,1412,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/25c048786c48939dc42a8f04bf78be4b.webp",981,1411,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/68fbf64559de7f77d8284d302e7bc711.webp",980,1409]